[Study of photodynamic treatment for P-388 lympho-leukemia in mice]

T S Lagoda; M A Kaplan; A M Bondar'; G V Ponomarev; B V Zubov; A P Nikitin; S V Egorova; E A Ivanov; A F Glushkova; A V Kirichenko; E V Iskra; N P Lepekhin; A I Brovin; O N Spichenkova

[Study of photodynamic treatment for P-388 lympho-leukemia in mice]

Vopr Onkol. 2011;57(1):75-80.

[Article in Russian]

Authors

T S Lagoda, M A Kaplan, A M Bondar', G V Ponomarev, B V Zubov, A P Nikitin, S V Egorova, E A Ivanov, A F Glushkova, A V Kirichenko, E V Iskra, N P Lepekhin, A I Brovin, O N Spichenkova

PMID: 21598713

Abstract

Data are presented on the results of photodynamic treatment (PDT) of mice DBA2 with transplantable lympho-leukemia P-388. Different regimens of photosensitizer Dimegin and emission were used. Both intravenous PDT and in combination with local PDT should be recommended.

Publication types

English Abstract

MeSH terms

Animals
Deuteroporphyrins / therapeutic use*
Leukemia, Experimental / drug therapy*
Lymphoma / drug therapy*
Mice
Mice, Inbred DBA
Neoplasms, Experimental / drug therapy
Photochemotherapy / instrumentation
Photochemotherapy / methods
Photosensitizing Agents / therapeutic use*
Transplantation, Heterologous
Treatment Outcome

Substances

Deuteroporphyrins
Photosensitizing Agents
dimegin(2,4-di-methoxyethyl)-deuteroporphyrin IX